Dr. Jin Li
Claim this profileShanghai East Hospital
Studies Solid Tumors
Studies Uterine Tumors
16 reported clinical trials
16 drugs studied
Area of expertise
1Solid Tumors
Stage IV
HER2 positive
Stage III
2Uterine Tumors
Stage III
Stage IV
Clinical Trials Jin Li is currently running
TROP2 ADC
for Cancer
A Phase I-II, First-in-Human Study of SKB264 in Patients with Locally Advanced Unresectable/Metastatic Solid Tumors who are refractory to Available Standard Therapies. Patient must have historically documented, incurable, locally advanced or metastatic cancer that are refractory to standard therapies of one of the following types: 1. Triple negative breast cancer 2. Epithelial ovarian cancer 3. Non-small cell lung cancer 4. Gastric adenocarcinoma/Gastroesophageal junction adenocarcinoma 5. Small cell lung cancer 6. HR+/ HER2-breast cancer 7. Head and neck squamous cell carcinoma 8. Endometrial carcinoma 9. Urothelial carcinoma
Recruiting1 award Phase 1 & 213 criteria
GQ1001
for Cancer
Phase I Dose Finding Study for GQ1001 in Patients with HER2-Positive Advanced Solid Tumors
Recruiting1 award Phase 18 criteria
More about Jin Li
Clinical Trial Related4 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Jin Li has experience with
- 3D185
- SKB264
- Recombinant Human Endostatin
- JMT103
- Cisplatin
- Fluorouracil
Breakdown of trials Jin Li has run
Solid Tumors
Uterine Tumors
Stomach Cancer
Breast Cancer
Gastroesophageal Junction Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jin Li specialize in?
Jin Li focuses on Solid Tumors and Uterine Tumors. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are HER2 positive.
Is Jin Li currently recruiting for clinical trials?
Yes, Jin Li is currently recruiting for 3 clinical trials in Shanghai Shanghai. If you're interested in participating, you should apply.
Are there any treatments that Jin Li has studied deeply?
Yes, Jin Li has studied treatments such as 3D185, SKB264, Recombinant Human Endostatin.
What is the best way to schedule an appointment with Jin Li?
Apply for one of the trials that Jin Li is conducting.
What is the office address of Jin Li?
The office of Jin Li is located at: Shanghai East Hospital, Shanghai, Shanghai 200123 China. This is the address for their practice at the Shanghai East Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.